Dr. Julian Jeberaeel, DO
Radiation Oncologist·Healthcare Technology Founder·Medical Consultant
Bringing clinical perspective to complex questions in cancer care, healthcare technology, and medical communication.
Board-certified in radiation oncology
About
Dr. Julian Jeberaeel is a board-certified radiation oncologist based in Metro Detroit and practices at Henry Ford Hospital. His approach combines advanced cancer treatment with something equally important: making sure patients understand their diagnosis, their options, and what comes next.
His clinical and research interests focus on precision treatment and preserving quality of life, including adaptive radiotherapy, stereotactic radiosurgery, brachytherapy, and organ-preserving approaches to cancer care. He believes the best cancer care is not only technologically sophisticated but also clear, thoughtful, and deeply human.
In conversation
Getting to know Dr. Jeberaeel.
A short introduction to his path into radiation oncology, how he works with patients, and the questions he keeps coming back to.
Expertise
Three areas of practice, closely related.
Radiation Oncology
Daily online adaptive radiotherapy, stereotactic radiosurgery and SBRT, HDR brachytherapy, and radiopharmaceutical therapy, alongside treatment planning, clinical decision-making, and patient communication.
Healthcare Innovation
Research and presentations evaluating language-model performance in clinical tasks, alongside clinical workflow design, patient-facing technology, and digital health product strategy grounded in daily practice.
Medical Consulting
Independent clinical review, standard-of-care analysis, expert-witness consultation, advisory work, and educational collaboration for legal, industry, and institutional audiences.
Engagements
Ways to work together.
Available for selected engagements with law firms, healthcare organizations, technology companies, and event organizers. Scope and fees are discussed directly.
Legal
Medical and medicolegal consulting
- Independent case review
- Radiation oncology standard-of-care analysis
- Radiation toxicity and late-effects review
- Medical-record review
- Expert-witness consultation
- Attorney and insurer education
Industry
Healthcare and AI advisory
- Clinical product review
- Physician workflow consulting
- Healthcare AI safety and usability
- Language-model evaluation against clinical tasks
- Oncology market insight
- Patient communication strategy
Audiences
Speaking and media
- Cancer myths and misconceptions
- Understanding radiation therapy
- Adaptive radiotherapy and organ preservation
- Artificial intelligence in medicine
- Improving the patient experience
- Building patient-centered healthcare technology
Founder
Second Set
A companion for people facing cancer, built to help patients and their families understand a diagnosis, keep their information in one place, and walk into every appointment ready to ask the questions that matter most.
Second Set grew out of a recurring problem in the oncology clinic: patients leave appointments holding more than anyone can absorb at once, often at the most overwhelming moment of their lives. It is built to make that information clear, organized, and genuinely useful.
Launching soon
Credentials
Training and appointments.
Licensed to practice medicine in the State of Michigan
Grosse Pointe, Michigan · 2025 to present
Chief Resident, 2024-2025 · NCI-designated cancer center, including pediatric radiation oncology and proton therapy
Roentgen Research Award recipient
Transitional Year · Ascension Providence Hospital, Southfield, Michigan · Outstanding Resident Award, 2020
- Campbell University School of Medicine · Doctorate of Osteopathic Medicine
- Campbell University · MS, Biomedical Sciences
- Michigan State University · BA, Political Science and Pre-Medical Studies
A prospective observational cohort measuring adaptive rescue and organ-at-risk dose reduction in daily online adaptive radiotherapy for bladder cancer on the Varian Ethos platform. IRB submission in progress.
- Assessment of OpenAI-Based Chatbot Performance in Responding to Patient Consult Inquiries. Practical Radiation Oncology, under review
- Durability of Response of Amniotic Bladder Therapy in Patients with Chronic Radiation Cystitis. American Urological Association Journal, 2024
- Pediatric Myeloid Sarcoma of the Testes Treated With Surgery and Adjuvant Radiation Therapy. Cureus, 2024
Contact
Start a conversation.
Tell me a little about the matter, the timeline, and what you need. Inquiries are answered personally, usually within two business days.
Prefer email? Write to email@drjulian.health.